Official PPA Removal From Market Sought In FDA Proposed Rule
This article was originally published in The Tan Sheet
Executive Summary
FDA would "assure the removal" of OTC drugs containing phenylpropanolamine (PPA) from the market and "prohibit future marketing of such products" under a proposed rule published in the Federal Register Dec. 22